Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
ERJ Open Research|July 9, 2024
Genomic epidemiology of <i>Mycobacterium abscessus</i> at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmissionJane E Gross, James D Finklea, Silvia M Caceres, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Annals of the American Thoracic Society|January 19, 2018
The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis BronchiectasisMark L Metersky, Timothy R Aksamit, Alan Barker, et al.
The New England Journal of Medicine|April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
MMWR. Morbidity and Mortality Weekly Report|May 9, 2024
Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico - Arizona and Colorado, 2022Minh-Vu H Nguyen, Nabeeh A Hasan, Vinicius Calado Nogueira De Moura, et al.
Mbio|January 25, 2022
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam ActionKhalid M Dousa, David C Nguyen, Sebastian G Kurz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 9, 2025
Genomic and epidemiologic investigation of Mycobacterium abscessus isolates in a cystic fibrosis center to determine potential routes of transmissionJane E Gross, Jason Fullmer, Gregory McCleland, et al.
American Journal of Public Health|October 3, 2009
Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitisJames D Heffelfinger, Pragna Patel, John T Brooks, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.
The European Respiratory Journal|November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary diseaseDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
ERJ Open Research|July 9, 2024
Genomic epidemiology of <i>Mycobacterium abscessus</i> at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmissionJane E Gross, James D Finklea, Silvia M Caceres, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Annals of the American Thoracic Society|January 19, 2018
The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis BronchiectasisMark L Metersky, Timothy R Aksamit, Alan Barker, et al.
The New England Journal of Medicine|April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
MMWR. Morbidity and Mortality Weekly Report|May 9, 2024
Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico - Arizona and Colorado, 2022Minh-Vu H Nguyen, Nabeeh A Hasan, Vinicius Calado Nogueira De Moura, et al.
Mbio|January 25, 2022
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam ActionKhalid M Dousa, David C Nguyen, Sebastian G Kurz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 9, 2025
Genomic and epidemiologic investigation of Mycobacterium abscessus isolates in a cystic fibrosis center to determine potential routes of transmissionJane E Gross, Jason Fullmer, Gregory McCleland, et al.
American Journal of Public Health|October 3, 2009
Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitisJames D Heffelfinger, Pragna Patel, John T Brooks, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.
The European Respiratory Journal|November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary diseaseDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Pageof 23